Biokine: BioLineRx Announces that a Combination of BL-8040, KEYTRUDA® and chemotherapy show high level of disease control in metastatic pancreatic cancer phase IIa trial – CBI

Homepage / Press Release / Biokine: BioLineRx Announces that a Combination of BL-8040, KEYTRUDA® and chemotherapy show high level of disease control in metastatic pancreatic cancer phase IIa trial

Press Release

Biokine: BioLineRx Announces that a Combination of BL-8040, KEYTRUDA® and chemotherapy show high level of disease control in metastatic pancreatic cancer phase IIa trial